Cardio-oncology is a specialty that has rapidly progressed during the last decade. Modern cancer therapies have shown a significant positive impact on the survival of cancer patients. Alongside the progress in oncological treatments came a wide array of cardiac toxicities. The development of cardiotoxicity can lead to unfortunate outcomes. Ensuring the optimal oncological treatment while protecting the heart and vascular system constitute the main objectives of the cardio-oncology unit. Its purpose is to prevent, treat and provide adequate follow-up of patients subject to cardiotoxic drugs.